Evogene (EVGN) Total Current Liabilities (2016 - 2025)

Evogene (EVGN) has disclosed Total Current Liabilities for 9 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 81.58% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, down 81.58% year-over-year, with the annual reading at $3.4 million for FY2025, 81.58% down from the prior year.
  • Total Current Liabilities hit $3.4 million in Q4 2025 for Evogene, down from $18.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $18.7 million in Q4 2024 to a low of $3.4 million in Q4 2025.
  • Historically, Total Current Liabilities has averaged $8.3 million across 5 years, with a median of $6.9 million in 2021.
  • Biggest five-year swings in Total Current Liabilities: surged 169.23% in 2024 and later tumbled 81.58% in 2025.
  • Year by year, Total Current Liabilities stood at $6.9 million in 2021, then fell by 18.27% to $5.6 million in 2022, then rose by 23.45% to $6.9 million in 2023, then surged by 169.23% to $18.7 million in 2024, then crashed by 81.58% to $3.4 million in 2025.
  • Business Quant data shows Total Current Liabilities for EVGN at $3.4 million in Q4 2025, $18.7 million in Q4 2024, and $6.9 million in Q4 2023.